Roadshow
Lilia Neuro
Lilia Neuro is the world’s first home-use wearable device that integrates EEG monitoring, Cranial Electrotherapy Stimulation (CES), and AI-driven neurofeedback training. It offers a non-pharmaceutical approach to improving anxiety and insomnia through vagus nerve modulation and personalized neurofeedback.
Unlike traditional CES or clinical neurofeedback therapies, Lilia features real-time AI EEG analysis, enabling users to quantify and track their neural response. By embedding AI, it brings lab-grade neurotraining into daily life. An open SDK further allows integration with digital health platforms to expand its applications.
The device completed usability evaluation in late 2024, with final design, wearability testing, and AI model validation in Q2 2025. Human trials are planned for Q3 2025. Positioned as a next-generation mental wellness platform, Lilia holds strong market potential.
- Established 2018
- Company BioPro Scientific
- Telephone +886-3-523-8290
- Email contact@bioproweb.com
- Address Unit 715, Center of Innovative Incubator, No. 101, Sec.2, Kangfu Rd., East Dist., Hsinchu City 30013, Taiwan
With expertise in neuroscience research and the development of bio-electronic medicine, our team has owned the core technologies, including proprietary wireless microchips for neuromodulation, algorithms for detecting pathological brain activities, shallow brain stimulation strategies, and a smart AIoT (AI and internet-of-things) system. We are on a mission to bring our success in building research tools to advance the diagnosis and treatment of movement disorders and beyond.